Skip to main content
. Author manuscript; available in PMC: 2014 Dec 1.
Published in final edited form as: Future Oncol. 2014 Feb;10(3):377–384. doi: 10.2217/fon.13.208

Table 1.

Selected study characteristics of study subjects (Umeå, Sweden, 1975–2008).

Characteristic Cases (n = 159) Controls (n = 286) p-value*
Age at blood draw, years (range) 26.8 (18.3–39.0) 26.6 (18.3–39.2)
Gestational day (range) 72.0 (38.0–105.0) 71.0 (42.0–118.0) 0.68
Parity at diagnosis 0.18
− 1, n (%) 38 (24%) 56 (20%)
− 2, n (%) 82 (52%) 145 (50%)
− ≥2, n (%) 39 (24%) 85 (30%)
Child's gender 0.63
− Male, n (%) 90 (57%) 155 (54%)
− Female, n (%) 69 (43%) 131 (46%)
Child's weight, g (range) 3470 (2520–4680) 3485 (2115–4770) 0.13
Child's length, cm (range) 50.0 (37.0–56.0) 50.0 (45.5–57.0) 0.61
Smoking 0.41
− No, n (%) 107 (67%) 204 (71%)
− Yes, n (%) 52 (33%) 81 (28%)
BMI, kg/m2 (range) 22.0 (17.7–30.5) 22.2 (16.8–45.0) 0.36
Age at diagnosis, years (range) 44.8 (25.5–60.8)
Lag-time, years (range) 17.8 (2.7–28.6)
Hormones
− hCG(mU/ml) 94,989 (57,757–140,430) 97,355 (55,016–141,279) 0.52
− Free β-hCG (ng/ml) 726 (68–1741) 803 (62–1942) 0.28
*

p-values calculated by conditional logistic regression.

Mean levels (10th–90th percentile) corresponding to hCG and free β-hCG concentrations centred at the median gestational day (71).

hCG: Human chorionic gonadotropin.